Nisa Investment Advisors LLC Has $41,000 Stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Nisa Investment Advisors LLC raised its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 40.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 1,040 shares of the company’s stock after purchasing an additional 301 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Acadia Healthcare were worth $41,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. State Street Corp raised its position in Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after buying an additional 95,613 shares during the period. JPMorgan Chase & Co. increased its holdings in shares of Acadia Healthcare by 17.0% in the 3rd quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock valued at $198,258,000 after purchasing an additional 454,044 shares during the period. LMR Partners LLP purchased a new stake in shares of Acadia Healthcare in the third quarter worth approximately $1,616,000. Principal Financial Group Inc. boosted its holdings in shares of Acadia Healthcare by 2.1% during the third quarter. Principal Financial Group Inc. now owns 656,889 shares of the company’s stock worth $41,653,000 after purchasing an additional 13,368 shares during the period. Finally, Sivik Global Healthcare LLC grew its position in Acadia Healthcare by 43.7% during the third quarter. Sivik Global Healthcare LLC now owns 115,000 shares of the company’s stock valued at $7,292,000 after purchasing an additional 34,997 shares in the last quarter.

Acadia Healthcare Stock Up 0.0 %

ACHC opened at $45.11 on Friday. Acadia Healthcare Company, Inc. has a twelve month low of $36.50 and a twelve month high of $87.77. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.07 and a current ratio of 1.07. The business has a 50 day moving average price of $41.79 and a 200 day moving average price of $55.69. The firm has a market cap of $4.19 billion, a P/E ratio of 14.79, a price-to-earnings-growth ratio of 1.78 and a beta of 1.29.

Acadia Healthcare (NASDAQ:ACHC) last posted its quarterly earnings data on Wednesday, October 30th. The company reported $0.91 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.90 by $0.01. The business had revenue of $815.60 million during the quarter, compared to the consensus estimate of $819.42 million. Acadia Healthcare had a net margin of 8.99% and a return on equity of 11.12%. Acadia Healthcare’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.91 EPS. Research analysts forecast that Acadia Healthcare Company, Inc. will post 3.39 EPS for the current year.

Wall Street Analysts Forecast Growth

ACHC has been the subject of a number of research reports. StockNews.com lowered shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. Deutsche Bank Aktiengesellschaft raised Acadia Healthcare from a “hold” rating to a “buy” rating and lifted their price objective for the company from $45.00 to $75.00 in a research report on Thursday, December 12th. KeyCorp raised Acadia Healthcare from a “sector weight” rating to an “overweight” rating and set a $70.00 target price on the stock in a research report on Tuesday, January 7th. Cantor Fitzgerald reiterated a “neutral” rating and set a $52.00 price target on shares of Acadia Healthcare in a report on Tuesday, December 10th. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $64.00 price objective on shares of Acadia Healthcare in a report on Friday, January 10th. One analyst has rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and an average price target of $70.22.

Acadia Healthcare Company Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.